FindTrial
Sign In

a study on anaesthesia for laproscopic surgeries.

A Randomized double blinded study on the recovery profile-single oral dose Gabapentin versus placebo in laparoscopic surgeries

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/12/010776
Enrollment
80
Registered
2017-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients coming for elective laparoscopis surgeries

Interventions

Intervention1: Group G: Group G:will receive Tab.Gabapentine 300mg I hr before surgery with sips of water Control Intervention1: Group P: placebo tablet(vitamin c) 1 hr before sugery with sips of wat

Sponsors

SRM Medical college and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I & II 18-70 yrs of age Laparoscopic surgeries- Diagnostic laproscopy, Laproscopic appendectomy, Laproscopic cholecystectomy,Laproscopic sterilization. Duration of surgery 1-2hrs

Exclusion criteria

Exclusion criteria: ASA III & IV Uncontrolled systemic illness Patients with history of allergy of study drugs

Design outcomes

Primary

MeasureTime frame
To study recovery profile of patients undergoing laparoscopic surgeries after oral Gabapentine 300mg 1 hour prior to surgery.Timepoint: 1hour prior to surgery to 24 hrs postop—

Secondary

MeasureTime frame
Timing of extrubation,onset of pain post operatively,post operative nausea and vomitingTimepoint: immediate postoperative period to 24hrs postoperative period—

Countries

India

Contacts

Public ContactPushparani A

SRM Medical college and Research Centre

pushpa82_dr@yahoo.com9003242601

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026